MedSales Network Blog
Careers, Hiring, and What’s Changing Now

Energy politics and pump prices are back in the news. Here is a practical look at how higher driving costs show up in medical sales territories—and what to ask employers before you sign.

Abbott announced FDA clearance and CE Mark for Ultreon™ 3.0, combining OCT coronary imaging with AI-driven insights for PCI. Here is what the news signals for interventional cardiology sales teams and hiring managers in 2026.

AI is quietly becoming a competitive advantage in medical device sales. Here’s how the top 1% of reps are using it to close more deals, build stronger relationships, and outperform their peers in 2026.

Medtronic’s acquisition of CathWorks signals a major shift toward AI-driven cardiovascular care. Here’s what it means for medical device sales reps and the future of interventional cardiology.

Tariffs, supply chain shifts, and “America First” manufacturing policies are influencing the cost and availability of medical devices in 2026. Here’s what it means for medical sales reps—and how to adapt.

Geopolitical tensions in the Strait of Hormuz can ripple through oil prices, global supply chains, and hospital budgets—ultimately reshaping how medical device sales reps sell in 2026.